Loading...
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas: A Phase 2 Clinical Trial
IMPORTANCE: There is a strong rationale for treating sarcomas with immunotherapy. OBJECTIVE: To assess the efficacy and safety of programmed cell death protein 1 (PD-1) targeting in combination with metronomic chemotherapy in sarcomas. DESIGN, SETTING, AND PARTICIPANTS: This was an open-label, multi...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5833654/ https://ncbi.nlm.nih.gov/pubmed/28662235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.1617 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|